Abstract：OBJECTIVE: To investigate the effect of low-dose methylprednisolone on serum tumor necrosis factor alpha (TNF-α) level in children with Mycoplasma pneumoniae pneumonia (MPP). METHODS: A case-control study was conducted among 38 children with MPP who received treatment in the Affiliated Hospital of Yan'an University between January and December 2012, and who had not received glucocorticoids before hospitalization. They were randomly divided into methylprednisolone treatment (n=20) and conventional treatment groups (n=18). The methylprednisolone treatment group was administered with methylprednisolone (1 mg/kg·d) by intravenous drip for three days in addition to conventional treatment. Serum samples were collected from both groups before treatment and on days 4 and 7 of treatment. Twenty-five children who underwent physical examination in the healthcare clinic during the same period were randomly selected as a normal control group, and serum samples were collected on the same day that the physical examination was performed. Serum TNF-α levels in the three groups were measured using enzyme-linked immunosorbent assay. RESULTS: On admission, the methylprednisolone treatment and conventional treatment groups had significantly higher serum TNF-α levels than the normal control group (P<0.01), but there was no significant difference between the methylprednisolone treatment and conventional treatment groups. On days 4 and 7 of treatment, the methylprednisolone treatment group had significantly lower serum TNF-α levels than the conventional treatment group (P<0.05; P<0.01). On day 7 of treatment, there was no significant difference in serum TNF-α level between the methylprednisolone treatment and normal control groups, but the conventional treatment group still had a significantly higher serum TNF-α level than the normal control group (P<0.01). CONCLUSIONS: Low-dose methylprednisolone can significantly decrease serum TNF-α level and inhibit inflammatory response in children with MPP, and may reduce damage caused by inflammatory response.
HE Jin-E,GAO Chun-Yan,LI Hong-Ri. Effect of low-dose methylprednisolone on serum TNF-α level in children with Mycoplasma pneumoniae pneumonia[J]. CJCP, 2013, 15(10): 850-853.
Ngeow YF, Suwanjutha S, Chantarojanasfifi T, Wang F, Saniel M, Alejandria M, et al. An Asian study on the prevalence of a typical respiratory pathogens in community-acquired pneumonia[J]. Int J Infect Dis, 2005, 9(3): 144-153.
[2]
Youn YS, Lee KY. Mycoplasma pneumoniae pneumonia in children[J]. Korean J Pediatr, 2012, 55(2): 42-47.
[3]
Vervloet LA, Vervloet VE, Tironi Junior M, Ribeiro JD. Mycoplasma pneumoniae-related community-acquired pneumonia and parapneumonic pleural effusion in children and adolescents[J]. J Bras Pneumol, 2012, 38(2): 226-236.
[4]
Ahn KK, Kwon D, Jung K, Ha Y, Seo MJ, Kim SH, et al. Identification of interleukin-1, tumor necrosis factor-alpha, and interleukin-6 expression in lungs from pigs naturally infected with Mycoplasma hyopneumoniae by in situ hybridization[J]. J Vet Med Sci, 2009, 71(4): 441-445.
[5]
Mukhopadhyay S, Hoidal JR, Mukherjee TK. Role of TNF-alpha in pulmonary pathophysiology[J]. Respir Res, 2006, 7(125): 1-9.
[6]
Baluk P, Yao LC, Feng J, Romano T, Jung SS, Schreiter JL, et al. TNF-α drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice[J]. Clin Invest, 2009, 119(10): 2954-2964.
[7]
Fernaders AB, Zin WA, Rocco PR. Corticosteroids in acute respiratory distress syndrome[J]. Braz J Med Biol Res, 2005, 38(2): 147-159.
[8]
Morrow MD. Implications of pharmacogenomics in the current and future treatment of asthma[J]. J Manag Care Pharm, 2007, 13(6): 497-505.
[9]
Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome[J]. N Engl J Med, 2006, 354(16): 1671-1684.
Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA. Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome[J]. Chest, 1987, 92(6): 1032-1036.
[15]
Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial[J]. Chest, 2007, 131(4): 954-963.
[16]
Lee HS, Lee JM, Kim MS, Kim HY, Hwangbo B, Zo JI. Low-dose steroid therapy at an early phase of postoperative acute respiratory distress syndrome[J]. Ann Thorac Surg, 2005, 79(2): 405-410.
